Tekla Capital Management LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 233 filers reported holding BEAM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$505,037
+4.3%
15,8170.0%0.02%
+11.1%
Q1 2023$484,317
-21.7%
15,8170.0%0.02%
-21.7%
Q4 2022$618,603
-18.0%
15,8170.0%0.02%
-25.8%
Q3 2022$754,000
+23.2%
15,8170.0%0.03%
+29.2%
Q2 2022$612,000
-32.5%
15,8170.0%0.02%
-25.0%
Q1 2022$906,000
-28.1%
15,8170.0%0.03%
-22.0%
Q4 2021$1,260,00015,8170.04%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$189,105,00091.90%
PATHWAY CAPITAL MANAGEMENT, LP 37,399$2,993,00016.59%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,390$17,960,00010.54%
HSG Holding Ltd 796,089$63,719,0004.73%
DC Investments Management, LLC 21,010$1,682,0004.17%
Monashee Investment Management LLC 268,820$21,516,0003.31%
Redmile Group, LLC 2,532,523$202,703,0002.86%
HAMILTON LANE ADVISORS LLC 98,761$7,905,0002.58%
Alphabet Inc. 640,792$51,289,0002.07%
Casdin Capital, LLC 818,820$65,538,0001.95%
View complete list of BEAM THERAPEUTICS INC shareholders